Effects of Medical Interventions on Suicidal Behaviors. SymposiumJAMISON, Kay R; BALDESSARINI, Ross J.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, 122 p.Conference Proceedings

Antidepressants and suicidal riskMÜLLER-OERLINGHAUSEN, B; BERGHÖFER, A.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 94-99Conference Paper

Neuroanatomical targets of neuroleptic drugs as revealed by fos immunochemistryFIBIGER, H. C.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 33-36, issn 0160-6689, SUPBConference Paper

Preferential activation of cortical dopamine neurotransmission by clozapine : functional significanceMOGHADDAM, B.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 27-29, issn 0160-6689, SUPBConference Paper

Seizures during clozapine therapyDEVINSKY, O; PACIA, S. V.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 153-156, issn 0160-6689, SUPBConference Paper

Clozapine and noradrenergic function : support for a novel hypothesis for superior efficacyBREIER, A.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 122-125, issn 0160-6689, SUPBConference Paper

Clozapine : 1994. SymposiumKANE, John M; MELTZER, Herbert Y; LIEBERMAN, Jeffrey A et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, issn 0160-6689, SUPBConference Proceedings

Depression screening as an intervention against suicideJACOBS, D. G.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 42-45Conference Paper

Suicide risk in patients with major depressive disorderANGST, J; ANGST, F; STASSEN, H. H et al.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 57-62Conference Paper

Lithium therapy and suicide riskNILSSON, A.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 85-88Conference Paper

Identification of the neural systems subserving the actions of clozapine : clues from immediate-early gene expressionDEUTCH, A. Y.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 37-42, issn 0160-6689, SUPBConference Paper

The risk of suicide in patients with bipolar disordersSIMPSON, S. G; JAMISON, K. R.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 53-56Conference Paper

G-CSF and the management of clozapine-induced agranulocytosisGERSON, S. L.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 139-142, issn 0160-6689, SUPBConference Paper

Motor and mental side effects of clozapineGERLACH, J; PEACOCK, L.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 107-109, issn 0160-6689, SUPBConference Paper

Efficacy of famotidine in the healing of active benign gastric ulceration : comparison of nonsteroidal anti-inflammatory- or aspirin-induced gastric ulcer and idiopathic gastric ulcerationBANK, S; BLUMSTEIN, M; GREENBERG, R. E et al.Clinical therapeutics. 1993, Vol 15, Num 1, pp 36-45, issn 0149-2918Article

The neurobiology of suicide risk : A review for the clinicianMANN, J. J; OQUENDO, M; UNDERWOOD, M. D et al.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 7-11Conference Paper

Electroconvulsive therapy and suicide risk. DiscussionPRUDIC, J; SACKEIM, H. A; JAMISON et al.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 104-110Conference Paper

Predictors of clozapine response in schizophreniaPICKAR, D; OWEN, R. R; LITMAN, R. E et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 129-132, issn 0160-6689, SUPBConference Paper

Clozapine in treatment-refractory mood disordersKIMMEL, S. E; CALABRESE, J. R; WOYSHVILLE, M. J et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 91-93, issn 0160-6689, SUPBConference Paper

Clozapine, negative symptoms, and extrapyramidal side effectsKANE, J. M; SAFFERMAN, A. Z; POLLACK, S et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 74-77, issn 0160-6689, SUPBConference Paper

The effects of clozapine on neurocognition : an overviewGOLDBERG, T. E; WEINBERGER, D. R.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 88-90, issn 0160-6689, SUPBConference Paper

Limbic-prefrontal connectivity and clozapineKNABLE, M. B; WEINBERGER, D. R.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 70-73, issn 0160-6689, SUPBConference Paper

Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptorsKERWIN, R. W; PILOWSKY, L; MUNRO, J et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 57-62, issn 0160-6689, SUPBConference Paper

Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents : Therapeutic implications. DiscussionMANJI, H. K; BEBCHUK, J. M; MOORE, G. J et al.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 27-41Conference Paper

Suicide, assisted suicide, and medical illness. DiscussionHENDIN, H; MANJI; ANGST et al.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 2, pp 46-52Conference Paper